IL119586A - Discontinuous library of a single biological unit and a method for its preparation - Google Patents
Discontinuous library of a single biological unit and a method for its preparationInfo
- Publication number
- IL119586A IL119586A IL11958696A IL11958696A IL119586A IL 119586 A IL119586 A IL 119586A IL 11958696 A IL11958696 A IL 11958696A IL 11958696 A IL11958696 A IL 11958696A IL 119586 A IL119586 A IL 119586A
- Authority
- IL
- Israel
- Prior art keywords
- fragments
- library
- discontinuous
- organism
- genome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11958696A IL119586A (en) | 1996-11-07 | 1996-11-07 | Discontinuous library of a single biological unit and a method for its preparation |
US09/297,668 US6984488B1 (en) | 1996-11-07 | 1997-11-04 | Determination and control of bimolecular interactions |
AU47928/97A AU4792897A (en) | 1996-11-07 | 1997-11-04 | Determination and control of bimolecular interactions |
PCT/IL1997/000353 WO1998020169A1 (fr) | 1996-11-07 | 1997-11-04 | Definition et gestion d'interactions bimoleculaires |
EP97910607A EP1012347A4 (fr) | 1996-11-07 | 1997-11-04 | Definition et gestion d'interactions bimoleculaires |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11958696A IL119586A (en) | 1996-11-07 | 1996-11-07 | Discontinuous library of a single biological unit and a method for its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
IL119586A0 IL119586A0 (en) | 1997-02-18 |
IL119586A true IL119586A (en) | 2001-09-13 |
Family
ID=11069461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11958696A IL119586A (en) | 1996-11-07 | 1996-11-07 | Discontinuous library of a single biological unit and a method for its preparation |
Country Status (5)
Country | Link |
---|---|
US (1) | US6984488B1 (fr) |
EP (1) | EP1012347A4 (fr) |
AU (1) | AU4792897A (fr) |
IL (1) | IL119586A (fr) |
WO (1) | WO1998020169A1 (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2334170A1 (fr) | 1998-07-27 | 2000-02-10 | Genentech, Inc. | Efficacite de transformation amelioree de l'expression a la surface des phages par modification d'une proteine de coque |
US20070160576A1 (en) | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
US20030148408A1 (en) | 2001-09-18 | 2003-08-07 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
KR100576674B1 (ko) | 2001-06-20 | 2006-05-10 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
KR100801388B1 (ko) | 2002-01-02 | 2008-02-05 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
MXPA04010092A (es) | 2002-04-16 | 2004-12-13 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
PL1641822T3 (pl) | 2003-07-08 | 2013-10-31 | Genentech Inc | Heterologiczne polipeptydy IL-17 A/F i ich zastosowania terapeutyczne |
US7329725B1 (en) | 2003-10-29 | 2008-02-12 | Nastech Pharmaceutical Company Inc. | Phage displayed Trp cage ligands |
PT2161283E (pt) | 2003-11-17 | 2014-08-29 | Genentech Inc | Composições que compreendem anticorpos contra cd79b conjugados a um agente de inibição do crescimento ou agente citotóxico e métodos para o tratamento de tumor de origem hematopoiética |
MX2007010922A (es) | 2005-03-10 | 2007-10-12 | Genentech Inc | Metodos y composiciones para modular la integridad vascular. |
EP2614839A3 (fr) | 2006-04-05 | 2015-01-28 | Genentech, Inc. | Méthode d'utilisation du BOC/CDO pour moduler l'émission des signaux du hedgehog |
WO2008021290A2 (fr) | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Protéines spécifiques d'organes et procédés d'utilisation |
US20100297103A1 (en) | 2006-09-14 | 2010-11-25 | Medical & Biological Laboratories Co., Ltd. | Antibody having enhanced adcc activity and method for production thereof |
WO2008083203A1 (fr) * | 2006-12-28 | 2008-07-10 | Saint Louis University | Identification des épitopes de protéines d'enveloppe virale multivalents |
US7875431B2 (en) | 2007-02-22 | 2011-01-25 | Genentech, Inc. | Methods for detecting inflammatory bowel disease |
CA2728473A1 (fr) | 2008-06-20 | 2009-12-23 | National University Corporation Okayama University | Anticorps contre un complexe ldl/.beta.2gpi oxyde et son utilisation |
US9182406B2 (en) | 2008-08-04 | 2015-11-10 | Biodesy, Inc. | Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability |
WO2011050194A1 (fr) | 2009-10-22 | 2011-04-28 | Genentech, Inc. | Procédés et compositions pour moduler l'activation d'hepsine d'une protéine de stimulation de macrophage |
JP5856065B2 (ja) | 2009-11-30 | 2016-02-09 | ジェネンテック, インコーポレイテッド | 腫瘍の診断と治療のための組成物と方法 |
JP5988436B2 (ja) | 2010-02-23 | 2016-09-07 | ジェネンテック, インコーポレイテッド | 腫瘍の診断と治療のための組成物と方法 |
KR20130079384A (ko) | 2010-05-03 | 2013-07-10 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
CA2831136A1 (fr) | 2011-03-21 | 2012-09-27 | Biodesy, Llc | Classification d'inhibiteurs de kinase a l'aide de techniques optiques non lineaires |
JP2014533927A (ja) | 2011-09-15 | 2014-12-18 | ジェネンテック, インコーポレイテッド | 分化を促進する方法 |
CA2850836A1 (fr) | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Procedes d'utilisation d'antagonistes de scd1 |
CN104168920A (zh) | 2012-01-18 | 2014-11-26 | 霍夫曼-拉罗奇有限公司 | 使用fgf19调控剂的方法 |
US20130209473A1 (en) | 2012-02-11 | 2013-08-15 | Genentech, Inc. | R-spondin translocations and methods using the same |
WO2013137920A1 (fr) | 2012-03-16 | 2013-09-19 | Genentech, Inc. | Protéines synthétiques stabilisées du point de vue conformationnel |
BR112014020173A8 (pt) | 2012-03-16 | 2017-07-11 | Hoffmann La Roche | Métodos para o tratamento de um melanoma, utilizações de um inibidor, composições, conjunto, método de inibição, método de identificação, método de ajuste do tratamento e invenção |
US9139863B2 (en) | 2012-03-16 | 2015-09-22 | Genentech, Inc. | Engineered conformationally-stabilized proteins |
EP2841951B1 (fr) | 2012-04-25 | 2019-12-11 | Biodesy, Inc. | Procédés de détection de modulateurs allostériques de protéines |
WO2013170191A1 (fr) | 2012-05-11 | 2013-11-14 | Genentech, Inc. | Procédés d'utilisation d'antagonistes de biosynthèse de nicotinamide adénine dinucléotide à partir de nicotinamide |
KR102158924B1 (ko) | 2013-03-15 | 2020-09-22 | 제넨테크, 인크. | Pd-1 및 pd-l1 관련 상태를 치료하기 위한 바이오마커 및 방법 |
WO2015116902A1 (fr) | 2014-01-31 | 2015-08-06 | Genentech, Inc. | Récepteurs couplés aux protéines g dans la signalisation hedgehog |
KR20170005016A (ko) | 2014-05-23 | 2017-01-11 | 제넨테크, 인크. | MiT 바이오마커 및 그의 사용 방법 |
CN114057857A (zh) | 2014-06-20 | 2022-02-18 | 豪夫迈·罗氏有限公司 | 基于chagasin的支架组合物、方法和应用 |
EP3237906B8 (fr) | 2014-12-23 | 2020-10-28 | Bluelight Therapeutics, Inc. | Fixation de protéines à des interfaces destinées à être utilisées en détection optique non linéaire |
JP6952605B2 (ja) | 2015-04-24 | 2021-10-20 | ジェネンテック, インコーポレイテッド | 多特異性抗原結合タンパク質 |
CA3011746A1 (fr) | 2016-02-06 | 2017-08-10 | Epimab Biotherapeutics, Inc. | Technologie fit-immunoglobuline et ses utilisations |
WO2018049275A1 (fr) | 2016-09-09 | 2018-03-15 | Genentech, Inc. | Inhibiteurs peptidiques sélectifs de frizzled |
WO2018152496A1 (fr) | 2017-02-17 | 2018-08-23 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Compositions et méthodes de diagnostic et de traitement de l'infection par le virus zika |
US11236151B2 (en) | 2017-04-25 | 2022-02-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection |
CN111094334A (zh) | 2017-07-19 | 2020-05-01 | 美国卫生与公众服务部 | 用于诊断和治疗乙肝病毒感染的抗体和方法 |
WO2020227554A1 (fr) | 2019-05-09 | 2020-11-12 | Genentech, Inc. | Procédés de préparation d'anticorps |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691170A (en) * | 1989-04-18 | 1997-11-25 | Therion Biologics | Generation of hybrid genes and proteins by virus-mediated recombination |
US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6031071A (en) * | 1996-01-24 | 2000-02-29 | Biophage, Inc. | Methods of generating novel peptides |
JPH1066577A (ja) * | 1996-08-07 | 1998-03-10 | Novo Nordisk As | 核酸プールおよびその製造方法 |
-
1996
- 1996-11-07 IL IL11958696A patent/IL119586A/en not_active IP Right Cessation
-
1997
- 1997-11-04 WO PCT/IL1997/000353 patent/WO1998020169A1/fr not_active Application Discontinuation
- 1997-11-04 AU AU47928/97A patent/AU4792897A/en not_active Abandoned
- 1997-11-04 EP EP97910607A patent/EP1012347A4/fr not_active Withdrawn
- 1997-11-04 US US09/297,668 patent/US6984488B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1998020169A1 (fr) | 1998-05-14 |
AU4792897A (en) | 1998-05-29 |
US6984488B1 (en) | 2006-01-10 |
IL119586A0 (en) | 1997-02-18 |
EP1012347A4 (fr) | 2005-03-16 |
EP1012347A1 (fr) | 2000-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL119586A (en) | Discontinuous library of a single biological unit and a method for its preparation | |
US6165722A (en) | Representations of bimolecular interactions | |
RU2136697C1 (ru) | Способ получения олигопептидов | |
Steward et al. | Synthetic peptides: a next generation of vaccines? | |
Jorgensen et al. | Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics | |
Manoutcharian et al. | Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis | |
KR100851728B1 (ko) | 특이적 병원균에 대한 항원을 동정하고 분리하여 생산하는 방법 | |
US20050208628A1 (en) | Methods and vectors for generating antibodies in avian species and uses therefor | |
US6605448B1 (en) | Method and means for sorting and identifying biological information | |
WO2001088162A2 (fr) | Procedes et vecteurs destines a generer des anticorps dans des especes aviaires et utilisations | |
CN102512670A (zh) | 化脓链球菌抗原 | |
DE69535360T2 (de) | Synthetische peptide und impfstoffe welche diese beinhalten | |
EP0552267A1 (fr) | Bacteriophages modifies par genie genetique et vaccins les contenant. | |
CN110408637B (zh) | 一种草鱼出血病酵母口服疫苗及应用 | |
JP4875497B2 (ja) | バクテリオファージナノ粒子を含む方法および組成物 | |
WO1987001374A2 (fr) | Procede et moyen de triage et d'identification d'informations biologiques | |
Lee et al. | Long-lasting germinal center responses to a priming immunization with continuous proliferation and somatic mutation | |
Collar et al. | Epitope-based vaccines against the chlamydia trachomatis major outer membrane protein variable domain 4 elicit protection in mice | |
WO2022067062A1 (fr) | Développement rapide d'un vaccin prophylactique à large spectre pour le sars-cov-2 à l'aide d'un système d'administration d'antigène à médiation par phage | |
AU3919993A (en) | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria | |
EP1238102B1 (fr) | Polynucleotides microbiens exprimes durant l'infection d'un hote | |
WO1992019263A1 (fr) | Vaccins intestinaux s'administrant par voie orale et s'utilisant contre des maladies provoquees par des organismes enteropathogenes au moyen d'antigenes capsules dans des microspheres biodegradables et biocompatibles | |
Ogrina et al. | Comparison of bacterial expression systems based on potato virus y-like particles for vaccine generation | |
WO1995005454A1 (fr) | Bacteriophages mis au point par genie genetique et vaccins les contenant | |
JPH02223594A (ja) | ヒトライノウイルスペプチド |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
HC | Change of name of proprietor(s) |
Owner name: RAMOT AT TEL-AVIV UNIVERSITY LTD. Free format text: FORMER NAMES:RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH AND INDUSTRIAL;DEVELOPMENT LTD. |
|
MM9K | Patent not in force due to non-payment of renewal fees |